Dr. Reddy's Laboratories Limited (BSE: 500124)
Health Care · Pharmaceuticals · IN
Rs1,195.10
+1.28% today · -4.1% 1Y
Dr. Reddy's Laboratories Limited (BSE: 500124) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $10.29B.
Over the last twelve months the share price has lost 4.1%, trading between 1.08K and 1.41K.
Tweenvest scores Dr. Reddy's Laboratories Limited across four factors: quality 84/100, value 51/100, growth 33/100, dividend 23/100. Its strongest factor is quality.
500124 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.29B
- Revenue (TTM)
- $3.50B
- P/E
- 30.09
- EPS
- 39.72
- Dividend yield
- 0.68%
- Beta (5Y)
- 0.25
- 52-week high
- Rs1,414.40
- 52-week low
- Rs1,080.05
- Avg volume (3M)
- —
- Shares outstanding
- 832.98M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Elanco Animal Health IncorporatedNYSE: ELAN | $11.45B | $22.78 | -0.61% |
| Laurus Labs LimitedNSEI: LAURUSLABS | $11.37B | Rs2,036.60 | +2.65% |
| Cipla LimitedNSEI: CIPLA | $10.86B | Rs1,301.00 | -3.20% |
| Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.SHSE: 600436 | $10.79B | CN¥119.82 | +1.38% |
| Mankind Pharma LimitedNSEI: MANKIND | $10.11B | Rs2,368.50 | -6.57% |
| Haisco Pharmaceutical Group Co., Ltd.SZSE: 002653 | $10.11B | CN¥61.02 | -1.87% |
| Aurobindo Pharma LimitedNSEI: AUROPHARMA | $10.07B | Rs1,693.00 | +0.97% |
| CSPC Innovation Pharmaceutical Co., Ltd.SZSE: 300765 | $9.44B | CN¥45.40 | -3.79% |
Figures last refreshed Oct 11, 2026.